Featured Publication: A synthetic mammalian network to compute population borders based on engineered reciprocal cell-cell communication
Congratulations to our clients on their December publication in BMC Systems Biology!
Dr. Matias Zurbriggen and team set out to create a system that models the detection of the border between two distinct cell populations. They designed a network where L-Tryptophan diffuses across the border from its sender/receiver cell population to the adjacent population. In turn, a second signaling protein, Interleukin-4 (Il-4), is released in a dose-dependent manner. Once Il-4 travels back to the sender/receiver cell, it activates expression of a fluorescent reporter protein at the border between the two populations. They measured the fluorescence at the border, in response to increased levels of Tryptophan/Il-4. Research like this has serious implications in the field of tissue engineering.
Mediomics Bridge-It Tryptophan Assay Kit was used in the study to measure the concentration of Tryptophan.
Mediomics is proud to serve such innovative clients and wishes them the best of luck in their future projects!
To see more details about how their system worked, check out the full article here.
Featured Publication: Pannexin 3 is required for normal progression of skeletal development in vertebrates
Congratulations to our clients for their publication in the FASEB Journal!
The role of Pannexin 3 in bone development has not yet been studied in vivo. Dr. Lee and team’s recent research provides evidence of the crucial roles of Panx3 in vertebrate skeletal development in vivo.
Mediomics’ Bridge-It cAMP designer Assay kit was used to measure cAMP levels in cells.
To find out more about Dr. Lee’s research, access the link here.
Mediomics is proud to serve such innovative clients in research and wishes them the best of luck in their future projects!
Featured Publication: Pfizer Oncology Team identifies potential therapeutic targets for lung cancer published in the EMBO Journal in May, 2015.
Featured Publication: Pfizer Oncology Team identifies potential therapeutic targets for lung cancer published in the EMBO Journal in May, 2015.
Mediomics wishes to congratulate Dr. Stephen Dann and his team for their important discovery of the reciprocal regulation between extracellular Met uptake and epigenetic state in malignant cells. They identified Lat1, an amino acid transporter, as a downstream biomarker of EZH2 activity and demonstrated the critical role of Lat1 in supporting tumor growth.
Mediomics is proud to serve such innovative clients in cancer research and wishes them the best of luck in their future projects!
To read more about Dr. Dann’s research, access the link here.
Congratulations to our clients in Japan on their February publication in Nature Medicine!
Congratulations to our clients in Japan on their February publication in Nature Medicine!
Dr. Keizo Nishikawa and team identified various metabolic processes involved in osteoclastogenesis, including the increased production of SAM. The research provides knowledge towards developing new therapeutic strategies for a variety of bone disorders.
Mediomics’ Bridge-It S-adenosyl Methionine Assay Kit was used in the study to detect SAM in osteoclast precursors and osteoclasts.
Mediomics is proud to serve such innovative clients and wishes them the best of luck in their future projects!
To read more about Dr. Nishikawa’s research, access the link here.
Congratulations to our clients on their March publication in PLOS One!
Congratulations to our clients on their March publication in PLOS One!